On the public citation graph
Molecular Subtypes of Amino Acid Metabolism-Related Genes Predicting Prognosis, Tumor Microenvironment Composition, and Therapeutic Response in Neuroblastoma
0 signed · 73 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1006/scbi.1995.0013openalex-extracted
Transcriptional control by E2F
inferredcites →https://doi.org/10.1007/s11864-023-01104-0openalex-extracted
Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for Acute Myeloid Leukemia
inferredcites →https://doi.org/10.1007/s40265-015-0399-5openalex-extracted
Dinutuximab: First Global Approval
inferredcites →https://doi.org/10.1016/0140-6736(91)91072-3openalex-extracted
Spontaneous regression of neuroblastoma detected by mass screening
inferredcites →https://doi.org/10.1016/0140-6736(91)92506-wopenalex-extracted
Bone-marrow infiltration in neuroblastoma
inferredcites →https://doi.org/10.1016/j.ccell.2019.09.002openalex-extracted
ATRX In-Frame Fusion Neuroblastoma Is Sensitive to EZH2 Inhibition via Modulation of Neuronal Gene Signatures
inferredcites →https://doi.org/10.1016/j.cell.2012.03.003openalex-extracted
MYC on the Path to Cancer
inferredcites →https://doi.org/10.1016/j.celrep.2022.111455openalex-extracted
Single-cell profiling of peripheral neuroblastic tumors identifies an aggressive transitional state that bridges an adrenergic-mesenchymal trajectory
inferredcites →https://doi.org/10.1016/j.ctrv.2009.05.003openalex-extracted
Survivin: A new target for anti-cancer therapy
inferredcites →https://doi.org/10.1016/j.ejca.2016.03.081openalex-extracted
RECIST 1.1—Update and clarification: From the RECIST committee
inferredcites →https://doi.org/10.1016/j.ejca.2020.05.010openalex-extracted
Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma
inferredcites →https://doi.org/10.1016/j.gpb.2022.01.004openalex-extracted
SynergyFinder Plus: Toward Better Interpretation and Annotation of Drug Combination Screening Datasets
inferredcites →https://doi.org/10.1016/j.immuni.2018.03.023openalex-extracted
The Immune Landscape of Cancer
inferredcites →https://doi.org/10.1016/j.immuni.2022.12.008openalex-extracted
Microenvironment-driven metabolic adaptations guiding CD8+ T cell anti-tumor immunity
inferredcites →https://doi.org/10.1016/j.neo.2017.09.006openalex-extracted
Molecular Classification Substitutes for the Prognostic Variables Stage, Age, and MYCN Status in Neuroblastoma Risk Assessment
inferredcites →https://doi.org/10.1016/j.pharmthera.2023.108411openalex-extracted
Lipid metabolism in Th17 cell function
inferredcites →https://doi.org/10.1016/j.smim.2021.101583openalex-extracted
Neutrophil metabolism in the cancer context
inferredcites →https://doi.org/10.1016/j.trecan.2021.04.007openalex-extracted
Metabolic Plasticity of Neutrophils: Relevance to Pathogen Responses and Cancer
inferredcites →https://doi.org/10.1016/s0002-9440(10)65042-0openalex-extracted
Expression of the ALK Tyrosine Kinase Gene in Neuroblastoma
inferredcites →https://doi.org/10.1016/s0304-3835(03)00079-xopenalex-extracted
A role for distinct cell types in determining malignancy in human neuroblastoma cell lines and tumors
inferredcites →https://doi.org/10.1016/s1470-2045(13)70095-0openalex-extracted
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study
inferredcites →https://doi.org/10.1038/nature07261openalex-extracted
Identification of ALK as a major familial neuroblastoma predisposition gene
inferredcites →https://doi.org/10.1038/nature07397openalex-extracted
Activating mutations in ALK provide a therapeutic target in neuroblastoma
inferredcites →https://doi.org/10.1038/ng.2529openalex-extracted
The genetic landscape of high-risk neuroblastoma
inferredcites →https://doi.org/10.1038/ng.3921openalex-extracted
Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries
inferredcites →https://doi.org/10.1038/nrc3580openalex-extracted
Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology
inferredcites →https://doi.org/10.1038/onc.2015.434openalex-extracted
ALK inhibitor resistance in ALKF1174L-driven neuroblastoma is associated with AXL activation and induction of EMT
inferredcites →https://doi.org/10.1038/s41392-023-01569-3openalex-extracted
Amino acid metabolism in health and disease
inferredcites →https://doi.org/10.1038/s41416-024-02666-yopenalex-extracted
Identification of MYCN non-amplified neuroblastoma subgroups points towards molecular signatures for precision prognosis and therapy stratification
inferredcites →https://doi.org/10.1038/s41467-023-38239-5openalex-extracted
Reversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastoma
inferredcites →https://doi.org/10.1038/s41467-023-42458-1openalex-extracted
Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth
inferredcites →https://doi.org/10.1038/s41568-019-0143-7openalex-extracted
The broken cycle: E2F dysfunction in cancer
inferredcites →https://doi.org/10.1038/s41571-022-00643-zopenalex-extracted
Advancing therapy for neuroblastoma
inferredcites →https://doi.org/10.1038/s41573-021-00339-6openalex-extracted
Targeting cancer metabolism in the era of precision oncology
inferredcites →https://doi.org/10.1038/s41587-021-01091-3openalex-extracted
Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data
inferredcites →https://doi.org/10.1038/s41588-021-00806-1openalex-extracted
Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma
inferredcites →https://doi.org/10.1038/s41698-023-00449-xopenalex-extracted
ALK fusions in the pan-cancer setting: another tumor-agnostic target?
inferredcites →https://doi.org/10.1038/s42003-020-01230-7openalex-extracted
An algorithm to quantify intratumor heterogeneity based on alterations of gene expression profiles
inferredcites →https://doi.org/10.1038/s42003-022-04209-8openalex-extracted
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma
inferredcites →https://doi.org/10.1038/s43018-020-00145-wopenalex-extracted
Super enhancers define regulatory subtypes and cell identity in neuroblastoma
inferredcites →https://doi.org/10.1038/s43018-022-00355-4openalex-extracted
MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis
inferredcites →https://doi.org/10.1038/s43018-022-00427-5openalex-extracted
Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypes
inferredcites →https://doi.org/10.1038/s44319-023-00038-wopenalex-extracted
Immunosurveillance encounters cancer metabolism
inferredcites →https://doi.org/10.1038/sj.bjc.6605014openalex-extracted
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
inferredcites →https://doi.org/10.1042/bj20101796openalex-extracted
Activating ALK mutations found in neuroblastoma are inhibited by Crizotinib and NVP-TAE684
inferredcites →https://doi.org/10.1056/nejmoa0911123openalex-extracted
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
inferredcites →https://doi.org/10.1093/annonc/mdr353openalex-extracted
A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer
inferredcites →https://doi.org/10.1093/annonc/mdt249openalex-extracted
A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer
inferredcites →https://doi.org/10.1101/gr.240663.118openalex-extracted
Benchmark and integration of resources for the estimation of human transcription factor activities
inferredcites →https://doi.org/10.1111/j.1476-5381.2012.01849.xopenalex-extracted
Crizotinib (PF‐02341066) reverses multidrug resistance in cancer cells by inhibiting the function of P‐glycoprotein
inferredcites →https://doi.org/10.1126/science.aax0249openalex-extracted
Single-cell transcriptional diversity is a hallmark of developmental potential
inferredcites →https://doi.org/10.1126/scitranslmed.3003728openalex-extracted
Escaping ALK Inhibition: Mechanisms of and Strategies to Overcome Resistance
inferredcites →https://doi.org/10.1146/annurev-bioeng-071516-044546openalex-extracted
Glutaminolysis: A Hallmark of Cancer Metabolism
inferredcites →https://doi.org/10.1158/0008-5472.can-21-0691openalex-extracted
Neuroblastoma Formation Requires Unconventional CD4 T Cells and Arginase-1–Dependent Myeloid Cells
inferredcites →https://doi.org/10.1158/0008-5472.can-21-1621openalex-extracted
Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors
inferredcites →https://doi.org/10.1158/0008-5472.can-22-1029openalex-extracted
Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma
inferredcites →https://doi.org/10.1158/1078-0432.ccr-09-2660openalex-extracted
Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification
inferredcites →https://doi.org/10.1158/1078-0432.ccr-14-3157openalex-extracted
FDA Approval: Ceritinib for the Treatment of Metastatic Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-20-3044openalex-extracted
Targeted Therapy of TERT -Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy
inferredcites →https://doi.org/10.1158/2159-8290.cd-15-1545openalex-extracted
Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade
inferredcites →https://doi.org/10.1182/blood-2007-11-125658openalex-extracted
IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells
inferredcites →https://doi.org/10.1186/s12943-021-01316-8openalex-extracted
The cancer metabolic reprogramming and immune response
inferredcites →https://doi.org/10.1186/s12943-021-01428-1openalex-extracted
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
inferredcites →https://doi.org/10.1186/s13046-022-02397-zopenalex-extracted
The immune landscape of solid pediatric tumors
inferredcites →https://doi.org/10.1186/s13073-021-01001-xopenalex-extracted
Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data
inferredcites →https://doi.org/10.1200/jco.2004.10.172openalex-extracted
Survivin Expression Predicts Poorer Prognosis in Anaplastic Large-Cell Lymphoma
inferredcites →https://doi.org/10.1200/jco.21.00086openalex-extracted
Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
inferredcites →https://doi.org/10.1200/jco.21.00278openalex-extracted
Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group
inferredcites →https://doi.org/10.1200/po.20.00181openalex-extracted
Differential Impact of ALK Mutations in Neuroblastoma
inferredcites →https://doi.org/10.1593/neo.06670openalex-extracted
Tissue Microenvironment Modulates CXCR4 Expression and Tumor Metastasis in Neuroblastoma
inferredcites →https://doi.org/10.4049/jimmunol.167.8.4747openalex-extracted
A Possible Role for CXCR4 and Its Ligand, the CXC Chemokine Stromal Cell-Derived Factor-1, in the Development of Bone Marrow Metastases in Neuroblastoma
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.